Report Overview

Germanys Neurology Devices market size stood at around USD XX.X billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around 7.8% during the forecast period.

The key factors propelling the growth of the market are the increasing incidence of neurological disorders, huge investments by private players in neurology devices, an increase in R&D in the field of neuro therapies.



Market Drivers

The primary driver of the German neurology market is the increasing incidence of neurological disorders like brain aneurysms, brain tumors, epilepsy, memory disorders, multiple sclerosis, Parkinsons disease, peripheral neuropathy, spinal cord tumor.

For instance, according to the German Brain Tumour Association, 2020, 25% of all cancer diagnoses in the young involve tumors in the brain and central nervous system. It is often children at the age of six-and-a-half, and boys more often than girls.

Furthermore, huge investments by private players in neurology monitoring devices & an increase in R&D in the field of neuro therapies also play their share in driving the market. However, the high cost of the devices and stringent regulations and guidelines for new devices is restraining market growth.